All terms in DRUGBANK

Label Id Description
Flortaucipir DB15033 [Flortaucipir is under investigation in clinical trial NCT03507257 (Longitudinal Early-onset Alzheimer's Disease Study Protocol).]
GTI-2040 DB15030 [GTI-2040 is under investigation in clinical trial NCT00084643 (GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors).]
Ado-P-Ch2-P-Ps-Ado DB04389
2-Aminobenzyl alcohol DB03058
Acetoacetyl-CoA DB03059
1-Hydroxy-2-Amino-3-Cyclohexylpropane DB04387
4-Piperidino-Piperidine DB03056
Malonaldehyde DB03057 [The dialdehyde of malonic acid. [PubChem]]
4-Carboxy-4-Aminobutanal DB04388
Psicose DB15087 [Psicose is under investigation in clinical trial NCT02459834 (The Fructose and Allulose Catalytic Effects (FACE) Trial).]
Ocrylate DB15086 [Ocrylate is under investigation in clinical trial NCT01918059 (Cosmetic Outcome Study of Lid Laceration Repair With Suture Versus Tissue Adhesive).]
Frovocimab DB15089 [Frovocimab is under investigation in clinical trial NCT01671085 (A Study of LY3015014 in Healthy Participants With High Cholesterol).]
Oleclumab DB15088 [Oleclumab is under investigation in clinical trial NCT03819465 (A Study of Novel Anti-cancer Agents in Patients With Previously Untreated NSCLC).]
Domagrozumab DB15083 [Domagrozumab is under investigation in clinical trial NCT01616277 (A Phase 1 Study To Evaluate The Safety And Tolerability Of PF-06252616 In Healthy Subjects).]
Cabiralizumab DB15082 [Cabiralizumab is under investigation in clinical trial NCT03502330 (APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma).]
Fulacimstat DB15085 [Fulacimstat is under investigation in clinical trial NCT02452515 (A Single-blind Pilot Study to Investigate Safety and Tolerability of the Chymase Inhibitor BAY1142524 in Clinically Stable Patients With Left-ventricular Dysfunction).]
GS-9191 DB15084 [GS-9191 is under investigation in clinical trial NCT00499967 (Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital Warts).]
Melanoma antigen recognized by T-cells 1 DB15081 [Melanoma antigen recognized by T-cells 1 is under investigation in clinical trial NCT01748747 (Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery).]
ELX-02 DB15080 [ELX-02 is under investigation in clinical trial NCT03309605 (Phase 1 Study of ELX-02 in Healthy Adult Subjects).]
Morinidazole DB15098 [Morinidazole is under investigation in clinical trial NCT03380793 (A Trial to Assess the Efficacy and Safety of Morinidazole in Patients With Appendicitis).]